This speech revealed the quintessential nature of science.
11 July, 2009
Obama's Address_Science is still a ideal mother of medicine
21 April, 2009
Tool 6.2_Awaken the Giant Within_Pain and Pleasure
Dear all:
Now that we have made the decision, why do we procrastinate to take action? Tony Robbins address this issue deep down to the core. We, humankind, are still affected by the very primitive emotion circuit in our brains. The driving force to change is strongly connected to the pain and pleasure emerging in our brains. Yes, pain and pleasure.
Pain, minuscular or catastrophic, is produced by our own perception system. Do you see the movie, Lawrence of Arabia? Lawrence stunned his friends by pinching out the flame, a seemingly unbelievable gesture. How could he do that? Didn't he feel the burning pain? He has programmed his perception to accept that sensation which is not tagged as "pain" in his own system. So he could bear that. On the contrary, we can program ourselves to feel the catastrophic pain which would have been a little chafe previously when we procrastinate. In brief, we can devise an emotion circuit with the self-made emotional threshold. Try to augment the pain whereby we can avert procratination successfully for fear. Once established, this circuit could operate more and more efficiently. This sort of self build-up could ultimately lead us to success.
In the same vein, we can put 'pleasure' into the same device we made ourselves. A sparkling pleasure could flare up into a scintilating one for the sake of this positive feedback system.
Use this 'Pain and Pleasure' gadget to plan your approach and act out the decision you've made. Robbins said dauntingly: "If you don't have a plan for your life, someone does."
15 April, 2009
Tool 6.1_Awaken The Giant Within_The Decision
Dear all:
I promised my weekly summary of this book "Awaken The Giant Within" and here it is. Three pages each day. Through Page 1 to 27, I was shocked that how little I knew about the meaning of "Decision".
I have ideas and I live many outcomes. But, how many decisions did I really make in my life? "If there's no action, you haven't trully decided." said Robbins. Without action, the so-called decision is false whereby "Niagara Syndrome" would prevail and ruin one's life.
Niagara Syndrome denotes a devastating picture: no decision, no action, just float with the currents of the river; when one finds there's a waterfall ahead, (s)he is doomed to drop.
Don't be afraid to make decisions. Don't fear mistakes. Robbins asks us to remember: success is truly the result of good judgement. Good judgement is the result of experience. Experience is the result of bad judgement!
Interestingly, how frequently should we make or practice to make decisios? The more frequently, the better. Just be sure to learn every lesson from those bad judgement. Through the repetitive training of our muscle of decision-making, it's getting more and more natural to land better results. So, he encourages us to "enjoy making decisions" because how could we know the next page we read will change our life forever? The next person we stand in line could open another possibility of our career. This sort of relentless expectancy will drive our lives passionate!
11 April, 2009
Teacher 2_Professor Ming-Ching Shen and Hwei-Fang Tien
Dear all:
A happy day. The annual meeting of Hematology Society of Taiwan. Coming to the straight 4th year, I made a presentation in it. Months ago, Professor Tien gave me a bunch of clinical data about adult acute myeloid leukemia (AML) and asked me to find any relations between WT1 mutation and the prognosis of these patients. Fortunately, we found that the combination of WT1 and CEBPA is a good way to stratify younger adult AML. With these two genetic markers, adult AML patients can be separated into three groups of distinct prognoses. The statistical significance is agreeable. Not only presented in this meeting, this result is hopefully to be published this year. This work is somewhat a sort of hand-made micro-microarray.
This is a picture depicting the transition of our academics. At the right, with much white hair, is Professor Shen who is still the arbiter of coagulation research in Taiwan. At the left, Professor Tien, a thesis student of Professor Shen, takes the lead of MDS research in Taiwan. We went to the dinner party this evening and shot this picture. I'm fortunate enough to be edified by their teaching.
08 April, 2009
Tool 7_The Old Love
Dear all:
I admit I bought this Sony PDA, i.e. CLIE, in a psychological impulse.
That was a time of Palm, a popular platform for PDA around 2003. Umpteen medical residents had their Palm-PDA, checking not-easy-to-learn formula every time when needed such as looking up how to calculate body surface area, serum osmolarity, or Cockcroft equation to calculate estimated CCr, etc. I dreamed to have one Palm-PDA then but restrained myself in face of its popularity until a fiasco happened at Grand Round.
As for the content I presented, I don't think I screwed up my debut at Grand Round which is definitely the biggest show every week for professionals of Internal Medicine, NTU Hospital.
Almost every 2nd-year medical resident has to endure the bombardment from professors in that occasion. Of course it takes much time for every presenter to pick a case, collect clinical data, construct a seemingly reasonable clinical algorithm, review the literature, make differential diagnoses, and rehearse with the Academic Chief Resident. Strategically speaking, I made a mistake. I picked a patient with hemolytic anemia who was treated initially as having biliary tract infection. Surely this embarrassed the attending physician in charge and I remember our Chief, Professor Pan-Chyr Yang, lambasted the clinical management for this patient. "Why did it take so long to attain such a straightforward diagnosis? Don't disable yourself as over-subspecialization! (I remember clearly he used the word, castration) And, you can imagine, what I could do was just to keep grounded at the podium and to try hard stuttering out what I'd prepared. That was a disaster and I felt totally wiped out after stepping down the stage.
To heal that chafe, I decided to comfort myself with a complacent gift, buying a Palm-PDA. That's why this CLIE came to me. I did spend some good times with it despite its weight. It can display PDF smoothly, record a small clip, shoot photos, build memos and contacts. But my attention departed from it later when this MacBook came to me. I carry MacBook to work everyday and CLIE shriveled day by day. This week, when I packed up stuff for moving, CLIE pops out and guides me revisiting this memory.
07 April, 2009
Tool 6_Awaken The Giant Within
29 March, 2009
School 7_To lodge in Baltimore
Consilience 8_Heisenberg's Uncertainty Principle
24 January, 2009
Consilience 7_Long Query
21 January, 2009
School 6_Boston, I'm coming!
Boston is cold but immunology is boiling. This is my first time to see snow. After the almost 20-hour trip, I landed in Boston. Although I was wiped out, it's worthwhile. Why?
First, there's a sparkling conversation with Dr. Rossi. He was recruited from Stanford with his outstanding research of aging in hematopoietic and immune system. I called at his office at three this afternoon. He stroke up the conversation by mentioning his latest endeavor in myelodysplastic syndrome (MDS). I have to say that this scholar is extremely smart on asking scientific question. When he talked about his experimental designing and showed his "hot" data, I can feel the heat in his eyes. That's the typical enthusiasm shining from a passionate mind. In the beginning, I questioned about an inherent problem of his experiment model, heterochronic parabiosis, which could have the problem of dilution of certain humoral and/or cellular factors. And he admitted by explaining a bar chart. Furthermore, he proposed a potential psychological stress in this kind of model which could lead to some cytokine perturbation. Then he asked me about the role of lymphocytes in MDS. Well, because he suspected that MDS is a stem cell disorder, some abnormalities are expected to happen in lymphocytes. I could not agree with that because what we see clinically is lymphocytic infiltration in bone marrow in the early phase of MDS. He and Peter Greenberg are cooperating on applying for an NIH funding. The focus is the effect of azacytidine on MDS and Dr. Rossi said that he cannot imagine this application could fail. I'm persuaded by him because the result of azacytidine on MDS is solid. He suggested me consider a rotation selection afterward and I'm happy to take that. Hopefully, I wish myself to get involved in the summer if I'm admitted to Harvard.
Second, today, I met Scott Loughhead, a Californian, who is my "Buddy" in this interview/recruitment weekend. He shared his experiences of interview last year. Quite straightforward. His apartment nearby is cozy and he's a fan of San Francisco Giants. Interestingly, he invited me to join the luncheon with Mark Anderson who comes from UCSF to give a talk this evening in the Weekly Immunology Seminar. Mark, trained at Harvard, is always smiling and he raised two questions in his conversation. Because I have a background of medicine, I happened to answer his questions about IPEX (Foxp3) and a rare manifestation of some kind of autoimmune disease relating to Aire.
Last, but not least, happily, I went to have a dinner last night with my three classmates: Hsienho, Ifan, and Shu-Hsien. They are almost the same as they were in college. Hsienho is on the edge to finish his thesis and going to get the degree these months. Ifan has got her post-doc job offer from Paris and she's taking it into consideration seriously. Shu-Hsien stills works as a PhD student of the BBS program of Harvard. They gave me some suggestions about interview generously and I shall follow their advises. I wish I can join in this Boston cluster later.
Tomorrow, I'm going to visit Professor Megan Sykes' lab in MGH-East which located in the Navy Yard. Her assistant emailed me a detail about its transportation. A little bit complicated for a newcomer in Boston but I'm confident to find that place. According to Shu-Hsien, MGH has a strong reputation of pathology undoubtedly. What we read about the clinical case discussion in NEJM just come from MGH. Prof. Megan Sykes had mentioned an interesting phenomenon about recipient lymphocyte infusion and I'm eager to discuss about it with her later.
Boston is cold but immunology is boiling!
John, in Boston













